Reporting of short-term clinical outcomes after esophagectomy: a systematic review
NS Blencowe, S Strong, AGK McNair… - Annals of …, 2012 - journals.lww.com
Objective: This review summarizes reporting of complications of esophageal cancer surgery.
Background: Accurate assessment of morbidity and mortality after surgery for cancer is …
Background: Accurate assessment of morbidity and mortality after surgery for cancer is …
Surgical treatment of esophageal cancer in the era of multimodality management
AS Borggreve, BF Kingma… - Annals of the New …, 2018 - Wiley Online Library
Over the last decades, the treatment of resectable esophageal cancer has evolved into a
multidisciplinary process in which all players are essential for treatment to be successful …
multidisciplinary process in which all players are essential for treatment to be successful …
Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer
Background & Aims Biomarkers are needed to risk stratify after chemoradiotherapy for
localized esophageal cancer. These could improve identification of patients at risk for cancer …
localized esophageal cancer. These could improve identification of patients at risk for cancer …
Is a pathological complete response following neoadjuvant chemoradiation associated with prolonged survival in patients with pancreatic cancer?
Objectives: To describe the survival outcome of patients with borderline resectable or locally
advanced pancreatic ductal adenocarcinoma (BR/LA-PDAC) who have a pathologic …
advanced pancreatic ductal adenocarcinoma (BR/LA-PDAC) who have a pathologic …
Increased rate of complete pathologic response after neoadjuvant FOLFIRINOX for BRCA mutation carriers with borderline resectable pancreatic cancer
T Golan, A Barenboim, G Lahat, I Nachmany… - Annals of Surgical …, 2020 - Springer
Background Neoadjuvant FOLFIRINOX is a standard-of-care treatment for BRPC patients.
Patients with gBRCAm who have demonstrated improved response to platinum-based …
Patients with gBRCAm who have demonstrated improved response to platinum-based …
Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer
PSN Van Rossum, AL Van Lier, M Van Vulpen… - Radiotherapy and …, 2015 - Elsevier
Purpose To explore the value of diffusion-weighted magnetic resonance imaging (DW-MRI)
for the prediction of pathologic response to neoadjuvant chemoradiotherapy (nCRT) in …
for the prediction of pathologic response to neoadjuvant chemoradiotherapy (nCRT) in …
The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative …
PSN Van Rossum, DV Fried, L Zhang… - Journal of Nuclear …, 2016 - Soc Nuclear Med
A reliable prediction of a pathologic complete response (pathCR) to chemoradiotherapy
before surgery for esophageal cancer would enable investigators to study the feasibility and …
before surgery for esophageal cancer would enable investigators to study the feasibility and …
[HTML][HTML] Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers
Gastroesophageal cancers (GOCs) represent some of the most common cancers globally
and are linked with poor survival rates. The current standard of care includes multimodal …
and are linked with poor survival rates. The current standard of care includes multimodal …
CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
Z Yang, B He, X Zhuang, X Gao, D Wang… - Journal of Radiation …, 2019 - academic.oup.com
The objective of this study was to build models to predict complete pathologic response
(pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell …
(pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell …
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer
D Vallböhmer, AH Hölscher, S DeMeester… - Annals of …, 2010 - journals.lww.com
Objective: To evaluate 5-year survival of patients with locally advanced esophageal cancer
(LAEC) who have undergone multimodality treatment with complete histopathologic …
(LAEC) who have undergone multimodality treatment with complete histopathologic …